FDA Announces New Limits On High-Dose Simvastatin (Zocor)

Links shared publicly online about this topic.

231
total visits

FDA Announces New Limits On High-Dose Simvastatin (Zocor)

The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in ra

View full resource at medicalnewstoday.com

Tags: Heart, Cholesterol Medication, Muscle, Diet and Nutrition, Drug, FDA, Zocor

Most Recently Shared on June 9, 2011 at 10:28 pm By:

James Underberg

FDA Announces New Limits On High-Dose #Simvastatin (#Zocor) http://bit.ly/mKSfcR #fb

11 months ago...

Retweet

Favorite

Also Shared By:

FDA announces new safety recommendations for high-dose simvastatin

fda.gov — “The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use.” View full resource at fda.gov

Most Recently Shared on June 10, 2011 at 12:55 pm By:

Cathy Rosenbaum Pharmacist, PharmD, and Doctor

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm258338.htm Talk 2 MD about decreasing Zocor 80 mg or switching prescriptions

11 months ago...

Retweet

Favorite

News releases

newsroom.heart.org — “AHA Newsroom, AHA News, heart news, heart health news, news releases, heart news releases, stroke news releases, stroke news, advocacy news, advocacy news releases, press releases, multimedia, podcast, video, audio interview” View full resource at newsroom.heart.org